1. Home
  2. SEV vs PYPD Comparison

SEV vs PYPD Comparison

Compare SEV & PYPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

SEV

Aptera Motors Corp.

HOLD

Current Price

$2.17

Market Cap

103.2M

Sector

Industrials

ML Signal

HOLD

Logo PolyPid Ltd.

PYPD

PolyPid Ltd.

HOLD

Current Price

$4.99

Market Cap

85.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SEV
PYPD
Founded
2019
2008
Country
United States
Israel
Employees
46
N/A
Industry
Auto Manufacturing
Medical/Dental Instruments
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
103.2M
85.1M
IPO Year
N/A
2014

Fundamental Metrics

Financial Performance
Metric
SEV
PYPD
Price
$2.17
$4.99
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$12.25
AVG Volume (30 Days)
219.1K
138.0K
Earning Date
05-16-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$17,757.14
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.29
$3.06
52 Week High
$11.24
$5.21

Technical Indicators

Market Signals
Indicator
SEV
PYPD
Relative Strength Index (RSI) 41.73 60.06
Support Level $1.97 $4.18
Resistance Level $3.26 $5.09
Average True Range (ATR) 0.14 0.29
MACD 0.03 0.03
Stochastic Oscillator 50.27 80.00

Price Performance

Historical Comparison
SEV
PYPD

About SEV Aptera Motors Corp.

Aptera Motors Corp engages in the development, production, and distribution of energy efficient solar-powered, battery-electric vehicles. The company has designed the Aptera vehicle to provide up to an estimated 40 miles per day by collecting energy from the sun and storing it in its proprietary battery pack. The company operates as a single reportable segment focused on the development of solar electric vehicles.

About PYPD PolyPid Ltd.

PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. The company's product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.

Share on Social Networks: